智通财经APP获悉,10月4日(周一)美股盘初,截至北京时间22:02,专注于神经学的生物制药公司Xenon Pharmaceuticals(XENE.US)涨74.78%,报27.265美元。早前,该公司公布了2b期X-Tole临床试验的积极结果,该临床试验评估了XEN1101的临床有... 网页链接
$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-072572 Act: 33 Size: 5 KB 网页链接
$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069465 Size: 5 KB 网页链接
$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069464 Size: 5 KB 网页链接
$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069462 Size: 14 KB 网页链接
$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069463 Size: 14 KB 网页链接
$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069466 Size: 14 KB 网页链接
$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069468 Size: 14 KB 网页链接
$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069467 Size: 14 KB 网页链接
$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-069439 Act: 33 Size: 6 KB 网页链接
$Xenon制药(XENE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-069340 Act: 33 Size: 230 KB 网页链接